Children with cancer who harbor germline variants in TP53 are more likely to develop second malignant neoplasms, often leading to poorer outcomes.18 Our study found, however, that second malignant neoplasms were not associated with RMS outcome by CPV status. The gene discussed is TP53; the disease is cancer.